JP2022551583A5 - - Google Patents
Info
- Publication number
- JP2022551583A5 JP2022551583A5 JP2022520290A JP2022520290A JP2022551583A5 JP 2022551583 A5 JP2022551583 A5 JP 2022551583A5 JP 2022520290 A JP2022520290 A JP 2022520290A JP 2022520290 A JP2022520290 A JP 2022520290A JP 2022551583 A5 JP2022551583 A5 JP 2022551583A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- chemical formula
- pharmaceutical composition
- following chemical
- acceptable complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962909006P | 2019-10-01 | 2019-10-01 | |
| US62/909,006 | 2019-10-01 | ||
| PCT/US2020/053369 WO2021067335A1 (en) | 2019-10-01 | 2020-09-30 | Benzoxazinone compounds as klk5/7 dual inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022551583A JP2022551583A (ja) | 2022-12-12 |
| JP2022551583A5 true JP2022551583A5 (enExample) | 2023-09-29 |
| JP7854389B2 JP7854389B2 (ja) | 2026-05-01 |
Family
ID=75274622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520290A Active JP7854389B2 (ja) | 2019-10-01 | 2020-09-30 | Ｋｌｋ５／７デュアル阻害剤としてのベンゾキサジノン化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US11643420B2 (enExample) |
| EP (1) | EP4037687B1 (enExample) |
| JP (1) | JP7854389B2 (enExample) |
| KR (1) | KR20220091488A (enExample) |
| CN (1) | CN114615984B (enExample) |
| AU (1) | AU2020359526A1 (enExample) |
| BR (1) | BR112022005881A2 (enExample) |
| CA (1) | CA3151626A1 (enExample) |
| ES (1) | ES3053975T3 (enExample) |
| IL (1) | IL291398B2 (enExample) |
| MX (1) | MX2022003929A (enExample) |
| WO (1) | WO2021067335A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20200040103A1 (en) | 2018-03-14 | 2020-02-06 | Genentech, Inc. | Anti-klk5 antibodies and methods of use |
| US12312414B2 (en) | 2019-09-18 | 2025-05-27 | Genentech, Inc. | Anti-KLK7 antibodies, anti-KLK5 antibodies, multispecific anti-KLK5/KLK7 antibodies, and methods of use |
| IL291398B2 (en) | 2019-10-01 | 2025-05-01 | Molecular Skin Therapeutics Inc | Benzoxazinone compounds as dual inhibitors of KLK5/7 |
| TW202304890A (zh) * | 2021-04-14 | 2023-02-01 | 美商百歐克斯製藥公司 | Klk5雙環雜芳香族抑制劑 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
| US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| KR890002631B1 (ko) | 1984-10-04 | 1989-07-21 | 몬산토 캄파니 | 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물 |
| IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
| CA1309556C (en) | 1987-06-09 | 1992-10-27 | Masayuki Kokubo | 4h-3,1-benzoxazin-4-one compounds and pharmaceutical composition thereoffor the inhibition of serine proteases |
| US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
| IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
| PH30995A (en) | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
| US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
| US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
| DE4134770A1 (de) | 1991-10-22 | 1993-04-29 | Basf Ag | Koernige bleichaktivatorzusammensetzung |
| US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
| TW333456B (en) | 1992-12-07 | 1998-06-11 | Takeda Pharm Ind Co Ltd | A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide. |
| US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
| US6087324A (en) | 1993-06-24 | 2000-07-11 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
| WO1997001331A2 (en) | 1995-06-27 | 1997-01-16 | Takeda Chemical Industries, Ltd. | Method of producing sustained-release preparation |
| TW448055B (en) | 1995-09-04 | 2001-08-01 | Takeda Chemical Industries Ltd | Method of production of sustained-release preparation |
| JP2909418B2 (ja) | 1995-09-18 | 1999-06-23 | 株式会社資生堂 | 薬物の遅延放出型マイクロスフイア |
| US5980945A (en) | 1996-01-16 | 1999-11-09 | Societe De Conseils De Recherches Et D'applications Scientifique S.A. | Sustained release drug formulations |
| US6264970B1 (en) | 1996-06-26 | 2001-07-24 | Takeda Chemical Industries, Ltd. | Sustained-release preparation |
| US6419961B1 (en) | 1996-08-29 | 2002-07-16 | Takeda Chemical Industries, Ltd. | Sustained release microcapsules of a bioactive substance and a biodegradable polymer |
| CA2184851A1 (en) | 1996-09-05 | 1998-03-06 | Cheng Chung Wu | Method of manufacturing a microweavable flatware article made of synthetic material, the article produced thereby and an ink-imprinted film component for use in making the flatware article |
| CA2217134A1 (en) | 1996-10-09 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Sustained release formulation |
| ES2221019T3 (es) | 1996-10-31 | 2004-12-16 | Takeda Chemical Industries, Ltd. | Preparacion de liberacion mantenida. |
| ZA9711385B (en) | 1996-12-20 | 1999-06-18 | Takeda Chemical Industries Ltd | Method of producing a sustained-release preparation |
| US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
| US6613358B2 (en) | 1998-03-18 | 2003-09-02 | Theodore W. Randolph | Sustained-release composition including amorphous polymer |
| IL137656A0 (en) | 1998-03-31 | 2001-10-31 | Warner Lambert Co | Benzoxazinones/benzothiazinones as serine protease inhibitors |
| KR19990085365A (ko) | 1998-05-16 | 1999-12-06 | 허영섭 | 지속적으로 약물 조절방출이 가능한 생분해성 고분자 미립구 및그 제조방법 |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| US7872052B2 (en) | 2003-06-06 | 2011-01-18 | Arexis Ab | Use of heterocyclic compounds as SCCE inhibitors |
| PT3097085T (pt) * | 2014-01-23 | 2020-10-08 | Sixera Pharma Ab | Derivados de benzoxazinona para tratamento de doenças de pele |
| IL291398B2 (en) | 2019-10-01 | 2025-05-01 | Molecular Skin Therapeutics Inc | Benzoxazinone compounds as dual inhibitors of KLK5/7 |
-
2020
- 2020-09-30 IL IL291398A patent/IL291398B2/en unknown
- 2020-09-30 US US17/037,910 patent/US11643420B2/en active Active
- 2020-09-30 MX MX2022003929A patent/MX2022003929A/es unknown
- 2020-09-30 JP JP2022520290A patent/JP7854389B2/ja active Active
- 2020-09-30 CN CN202080069819.7A patent/CN114615984B/zh active Active
- 2020-09-30 KR KR1020227014268A patent/KR20220091488A/ko active Pending
- 2020-09-30 CA CA3151626A patent/CA3151626A1/en active Pending
- 2020-09-30 BR BR112022005881A patent/BR112022005881A2/pt unknown
- 2020-09-30 EP EP20872712.3A patent/EP4037687B1/en active Active
- 2020-09-30 WO PCT/US2020/053369 patent/WO2021067335A1/en not_active Ceased
- 2020-09-30 ES ES20872712T patent/ES3053975T3/es active Active
- 2020-09-30 AU AU2020359526A patent/AU2020359526A1/en active Pending
-
2023
- 2023-04-03 US US18/295,009 patent/US12281123B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7745892B2 (ja) | Ｎ４－ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途 | |
| RU2606947C2 (ru) | Борсодержащие малые молекулы | |
| RU2325389C2 (ru) | Композиция и производные замещенного азаиндолоксоацетапиперазина, обладающие противовирусной активностью | |
| JPS62230722A (ja) | 肥満および／または関連状態の治療剤 | |
| CN101595217A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的1H-咪唑并[4,5-c]喹啉-4-胺类及其相关化合物的前药 | |
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| CN116157387A (zh) | 异喹啉化合物及其在治疗AhR失衡中的用途 | |
| CN108601760A (zh) | 艾日布林的合成中的中间体及相关的合成方法 | |
| BR0015117A (pt) | Composto, composição farmacêutica, métodos para tratar um paciente quanto a dor, quanto a doença de parkinson, quanto ao câncer, quanto a aids, processos para preparar um composto, para preparar (1s, 2s) -n- (1-hidróxi-1,2-diidro-naftalen-2-il)- benzeno sulfonamida, e para preparar o éster dimetìlico do áciso (1s*,2r*) -2- (hidróxi -1,2- diidro - naftalen -2- il ) malÈnico | |
| CN103483158B (zh) | 一种二苯乙烷衍生物及其应用 | |
| RU2001121650A (ru) | Композиции для лечения кожных заболеваний | |
| CN113101289A (zh) | 烟酰胺在制备治疗手足皮肤反应制剂中的应用 | |
| RU2004102398A (ru) | Производные бензо[g]хинолина для лечения глаукомы и близорукости | |
| CA2435611A1 (en) | Alpha-amino-n-hydroxy-acetamide derivatives | |
| US20180085345A1 (en) | Methods of tracking skin conditions using cyclolignan compounds | |
| JP4166433B2 (ja) | ホルモン依存性疾患治療剤 | |
| JP2024509993A (ja) | セレコキシブのプロドラッグ及びその調製方法並びに適用 | |
| WO2001007418A3 (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
| RU2005115102A (ru) | Новые противоопухолевые соединения | |
| JPS60158149A (ja) | 炎症抑制作用を有する１，４‐ナフトキノン誘導体 | |
| JP4361789B2 (ja) | 体表の過剰増殖疾患の処置 | |
| FR2470110A1 (fr) | Derives de la decrapenylamine, leurs sels acides d'addition et composition pharmaceutique renfermant ces produits | |
| JPH10175852A5 (enExample) | ||
| RU2171803C2 (ru) | Содержащие диол производные хинолина, способ их получения, фармацевтический препарат на их основе и способ ингибирования | |
| EP0213130B1 (en) | Trichloroacetortoxy-3,4,5,6-tetrachlorobenzoic acid chemoterapeutically active against cutaneous and subcutaneous benigne neoformations, process for its preparation and compositions conmtaining the same |